Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Am J Obstet Gynecol ; 226(3): 379-383, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-34111406

RESUMEN

In the past, the reproductive freedom of African American women was hindered by forced reproduction and sterilization campaigns. Unfortunately, these involuntary practices have now mostly been replaced by inequality because of disproportionate tubal factor infertility rates within African American communities. Our work aimed to describe the inequities in increased rates of pelvic inflammatory disease and tubal factor infertility as it relates to African American women. In addition, we highlighted the need for improved access to screening and treatment of sexually transmitted infections, access to barrier contraception, and health literacy related to the understanding and prevention of tubal factor infertility in African American women.


Asunto(s)
Infertilidad Femenina , Infertilidad , Enfermedad Inflamatoria Pélvica , Negro o Afroamericano , Femenino , Libertad , Humanos , Infertilidad/complicaciones , Infertilidad Femenina/etiología , Enfermedad Inflamatoria Pélvica/diagnóstico , Reproducción
2.
Clin Perinatol ; 46(2): 187-201, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-31010555

RESUMEN

Cerebral palsy occurs more often in preterm than in term deliveries and is one of the major neurologic injuries seen in preterm infants. Magnesium sulfate has been found to reduce the risk of cerebral palsy in patients at risk of delivery before 32 weeks' gestational age. Multiple large clinical trials have shown this effect. The authors recommend magnesium sulfate bolus followed by continuous dosing of magnesium sulfate in those at risk of delivery before 32 weeks' gestation until delivery occurs or is no longer imminent. This article also discusses novel and emerging therapies for the prevention of cerebral palsy.


Asunto(s)
Parálisis Cerebral/prevención & control , Sulfato de Magnesio/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Trabajo de Parto Prematuro , Nacimiento Prematuro , Darbepoetina alfa/uso terapéutico , Eritropoyetina/uso terapéutico , Femenino , Hematínicos/uso terapéutico , Humanos , Hipotermia Inducida , Recién Nacido , Recien Nacido Prematuro , Precondicionamiento Isquémico , Intercambio Materno-Fetal , Trasplante de Células Madre Mesenquimatosas , Neuroprotección , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA